Adults with prediabetes who took metformin for more than two decades showed no reduction in heart disease, cancer, or death ...
The combination therapy of metformin and GLP-1 receptor agonists (GLP-1 RAs) demonstrates superior safety over monotherapy, ...
By Nancy Lapid July 22 (Reuters) - The risk of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, ...
July 22 (Reuters) – The risk ‌of hair loss in patients taking GLP-1 drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. At two or more years after ...
ETHealthworld.com brings latest astrazeneca india news, views and updates from all top sources for the Indian Health industry.